Your browser doesn't support javascript.
loading
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.
Denton, Christopher P; Goh, Nicole S; Humphries, Stephen M; Maher, Toby M; Spiera, Robert; Devaraj, Anand; Ho, Lawrence; Stock, Christian; Erhardt, Elvira; Alves, Margarida; Wells, Athol U.
Affiliation
  • Denton CP; Centre for Rheumatology and Connective Tissue Diseases, University College London Division of Medicine, London, UK.
  • Goh NS; Respiratory and Sleep Medicine, Austin Health, and Institute for Breathing and Sleep, Melbourne, VIC, Australia.
  • Humphries SM; Department of Radiology, National Jewish Health, Denver, CO, USA.
  • Maher TM; National Heart and Lung Institute, Imperial College London, London, UK.
  • Spiera R; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Devaraj A; Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA.
  • Ho L; Department of Radiology, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK.
  • Stock C; Center for Interstitial Lung Diseases, University of Washington, Seattle, WA, USA.
  • Erhardt E; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Alves M; mainanalytics GmbH, Sulzbach, Germany.
  • Wells AU; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Rheumatology (Oxford) ; 62(5): 1870-1876, 2023 05 02.
Article in En | MEDLINE | ID: mdl-36111858

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Lung Diseases, Interstitial Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article